RxDoctor Payments Data

Patrick Grohar

Pediatric Hematology-Oncology · Ann Arbor, MINPI 1225175201

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,630 of the $7,630 with a category attached, or 100.0%. Orphai Therapeutics Inc. accounts for 62.3% of it on its own, with 1 other manufacturer making up the rest.

$7,630in general payments, 2019–2025

Across 2 payments — averaging $3815.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orphai Therapeutics Inc.$5K
  • Jazz Pharmaceuticals Inc.$3K
$1,548,448in research payments, 2019–2025

Across 32 payments — averaging $48,389 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$948K
  • Jazz Pharmaceuticals Inc.$600K

What the payments were for

  • Consulting fees$7,630100%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Orphai Therapeutics Inc.1$4,750
Jazz Pharmaceuticals Inc.1$2,880

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,630 in reported general payments places this provider in the 75th percentile of 84 pediatric hematology-oncology providers in Michigan.

See all pediatric hematology-oncology providers in Michigan

Other pediatric hematology-oncology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →